Skip to content

Newsroom

Connect with trending topics, events, the industry's best thinkers, news and information.

02/18/2020

Allscripts and Manorama Infosolutions partner to deliver a Health Information Exchange and population health management services in India and other emerging markets

dbMotion™ Solution to reach 1.4 billion people through strategic partnership

CHICAGO–(BUSINESS WIRE)–Feb. 18, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced its strategic partnership with Manorama Infosolutions, a healthcare IT company located in India, to deliver an integrated Healthcare Management Information System and Health Information Exchange platform. Manorama will Integrate Allscripts interoperability platform, dbMotion Solution with Lifeline Suite of solutions, extending its reach to an additional 1.4 billion people.

Manorama Infosolutions is a pioneer in healthcare IT providing enterprise solutions globally, offering solutions for public health, corporate hospitals and medical centers. Manorama Infosolutions delivers a comprehensive portfolio of healthcare products and services using the Microsoft platform. The partner offers deep expertise in innovative solutions such as electronic medical records, telemedicine, and connected devices such as mobile apps and patient portals, impacting patient safety along with quality of healthcare delivery.

The dbMotion Solution harmonizes data from all disparate clinical and financial source systems to deliver it in a usable way to the point of care in support of clinical decision making and to analytics engines based on organizational needs. The impact of dbMotion has been demonstrated to reduce the cost of care delivery, enables physicians to provide more informed patient care and drives clinical outcomes and improve patient satisfaction and confidence in their care.

“Government bodies responsible for healthcare desire a platform that enables them to collect data, integrate and act on this public ‘health information,’” said Manorama Infosolutions CEO and MD, Mrs. Ashvini Danigond. “By offering the integrated solution of dbMotion, we will enable health policy administrators and authorities to implement and track healthcare policies effectively through the use of population health and central EHRs, as well as empower them to make more informed decisions for safer, more efficient policy implementation.”

“The dbMotion Solution enables healthcare organizations all around the world to access a single record across the continuum, get aggregated data within the native EHR and use multiple, disparate EHR systems,” said Paul M. Black, Chief Executive Officer of Allscripts. “Our partnership with Manorama will further expand the company’s reach to under-served areas in India and other emerging markets, contribute to Allscripts larger reseller strategy and showcase the company’s continued growth internationally.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

02/14/2020

Allscripts to release fourth-quarter and full-year 2019 financial results March 2

CHICAGO–(BUSINESS WIRE)–Feb. 14, 2020–
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2019, after the close of stock market hours on Monday, March 2nd. Allscripts management plans to host a conference call and webcast to discuss the company’s earnings and other information at 4:30 p.m. Eastern Time that same day.

Fourth-Quarter and Full-Year 2019 Financial Results Call Details

The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on March 2, 2020. The announcement will also be available at Allscripts investor relations website.

To listen to the conference call, participants may log onto the Allscripts Investor Relations website. Participants also may access the conference call by dialing (877) 269-7756 or 201-689-7817 and requesting Conference ID # 13699139.

A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts investor relations website or by calling (877) 660-6853 or (201) 612-7415 – Conference ID # 13699139.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

 

Source: Allscripts

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

02/12/2020

Memorial Sloan Kettering Cancer Center Extends Allscripts Sunrise™ Agreement

CHICAGO–(BUSINESS WIRE)–Feb. 12, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Memorial Sloan Kettering Cancer Center (MSK), has extended its engagement with Allscripts Sunrise™ through 2026.

Allscripts Sunrise is an integrated electronic health record that can connect all aspects of care. As an evidence-based single platform, Sunrise has integrated analytics that can support core care venues across the enterprise.

“The Allscripts Sunrise platform has been a key component in our clinical platform for two decades,” said Memorial Sloan Kettering Cancer Center’s Chief Operating Officer, Kathryn Martin. “We look forward to continued collaboration with the Health IT company, working to meet the needs of our clinicians and, most importantly, our patients.”

“We’re honored to continue our work with Memorial Sloan Kettering Cancer Center, the largest and oldest private cancer center in the world,” said Allscripts CEO Paul Black. “Our more than 20-year relationship has helped many patients within the cancer community receive world-class care and we’re certain that the cancer center’s extension of its Sunrise engagement will be the right fit for its future success.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

 

Source: Allscripts

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

02/06/2020

Allscripts Sunrise™ Wins Best in KLAS Award

Acute solution named 2020 Best in KLAS – Global Acute Care EMR (Canada)

RICHMOND, British Columbia–(BUSINESS WIRE)–Feb. 6, 2020–
KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS – Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical solution that provides advanced decision support, such as Computerized Physician Order Entry (CPOE), to help hospital teams improve patient care. According to the 2020 Best in KLAS – Global Acute Care EMR (Canada) report, the solution outpaced competitors in delivering new technology and earning customer loyalty.

“Providers and payers demand better performance, usability, and interoperability from their vendor partners every year,” says Adam Gale, President of KLAS. “Best in KLAS winners set the standard of excellence in their market segment. Earning a Best in KLAS award should both excite and humble the recipients. It serves as a signal to providers that they can expect the best from the winning vendors.”

KLAS Research independently monitors healthcare technology performance through the active participation of users. Healthcare professionals evaluate the software they use, and KLAS Research analyzes and publishes the results in its annual Best in KLAS: Global Software (Non-US) report.

“This Best in KLAS award demonstrates Allscripts Sunrise comprehensive and flexible features that our clients require when facing today’s challenges in delivering complex care models,” said President of Allscripts Global, Alan Fowles. “Allscripts continues to focus on delivering industry leading, highly coordinated service to our clients globally and is proud that Sunrise is helping hospitals and health systems around the globe improve the clinician experience and provide quality patient care.”

Used by healthcare organizations across the globe, Allscripts Sunrise is an integrated electronic patient record that connects all aspects of care, including acute, ambulatory, surgical, radiology and personalized medicine. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with advanced analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that can increase access and convenience for the consumer.

Allscripts celebrates this award with our Canadian clients who continue to deliver exceptional care every day.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

02/05/2020

Sunnybrook Health Sciences Centre selects Allscripts iProcedures

Canada provider to implement Allscripts iProcedures Anesthesia system to drive effective electronic documentation and charting

TORONTO–(BUSINESS WIRE)–Feb. 5, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Canada’s Sunnybrook Health Sciences Centre is continuing its partnership with Allscripts by implementing the iProcedures electronic Anesthesia Information Management Solution (AIMS). The solution will be used in all operating rooms, labour and delivery and other anesthesia-related areas at Sunnybrook Health Sciences Centre’s Bayview and Holland Centre sites.

Sunnybrook Health Sciences Centre began as a hospital for Canadian veterans, and has since grown into a fully affiliated teaching hospital of the University of Toronto, evolving to meet the needs of its growing community. The hospital sees nearly 1.3 million patients each year across three campuses and is also home to Canada’s largest trauma centre. Sunnybrook’s groundbreaking research changes the way patients are treated around the world.

Already an Allscripts Patient Flow™ user, Sunnybrook Health Sciences Centre looks to uphold its vision to invent the future of healthcare by implementing iProcedures AIMS to enable users to create complete anesthesia records through automated collection and storage of data from anesthesia-related machines. The iProcedures solution can reduce duplication of documentation, improve efficiency of perioperative process, provide data analysis to aid decision making and generate reports for quality assurance and for research proposes.

“In Allscripts, we have a dedicated partner, one that shares our mission of driving the best care for our patients when it matters most,” said Dr. Andy Smith, Sunnybrook’s president and CEO. “Ensuring our surgical departments have the most comprehensive tools is critical to our continued success.”

iPro Anesthesia is a cloud-based, mobile anesthesia information management system designed by anesthesiologists to automate anesthesia documentation and offer true clinician-driven functionality. A comprehensive end-to-end solution that can produce a more complete, compliant and legible anesthesia record, it can improve documentation, operating room efficiency, patient safety and medication management.

“We’re proud to expand our successful partnership with Sunnybrook,” said Allscripts CEO Paul Black. “Documentation is an important element across all clinical departments and it’s an especially critical measure in the operating theatre. With iProcedures AIMS, Sunnybrook has chosen the solution it needs to deliver the excellent care Sunnybrook’s patients expect.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

01/15/2020

PIH Health extends partnership with Allscripts through 2025

CHICAGO–(BUSINESS WIRE)–Jan. 15, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that PIH Health, a healthcare system based in Whittier, California, has extended its solutions, services and outsourcing engagement with Allscripts through 2025.

PIH Health is a fully integrated, nonprofit, regional healthcare delivery network comprised of three hospitals, a host of outpatient medical offices, and a multi-specialty medical group including home health and hospice care. PIH Health serves more than 3 million residents in the greater Los Angeles and Orange County areas, including the San Gabriel Valley.

PIH Health has used Allscripts solutions since 2004, including the Sunrise™ EHR platform, the Allscripts TouchWorks® EHR platform and the Allscripts CareInMotion™ population health suite. With this extension the health system is also expanding use of these solutions to its newly acquired PIH Good Samaritan Hospital and has cemented itself as one of Allscripts largest client relationships.

“The partnership between PIH Health and Allscripts has helped drive comprehensive care for our patient communities for nearly two decades,” said Peggy Chulack, PIH Health System Chief Administrative Officer. “We look forward to continuing our work together, as Allscripts solutions help enable our health system to provide safer care, improve clinician workflows, increase practice efficiencies, deliver clear and consistent patient records, and offer an intuitive patient portal experience.”

“We are honored to continue our long-standing partnership with PIH Health, a leading health system focused on delivering excellent care to its patients across all settings,” said Allscripts CEO Paul Black. “Healthcare providers must anticipate how our industry will continue to evolve and how patients’ needs may change, and we’re proud to continue this journey as PIH Health’s trusted health IT partner.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

01/14/2020

Allscripts Announces Preliminary 2019 Results

Management to present at J.P. Morgan Healthcare Conference on January 15

CHICAGO–(BUSINESS WIRE)–Jan. 14, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced preliminary 2019 financial results.

The company anticipates bookings(1) for 2019 of between $1,090 million to $1,110 million, an increase from the prior outlook of between $1,050 million to $1,100 million. This result implies annual bookings growth of 13 percent to 15 percent.

GAAP and Non-GAAP revenue for the fourth quarter of 2019 is expected to be between $450 million to $455 million. This represents a year-over-year increase of 2 percent to 3 percent for non-GAAP revenue.

The company is also reaffirming its full year 2019 non-GAAP earnings per share outlook provided on November 4, 2019.

The preliminary financial information presented in this press release is based on expectations and may be adjusted as a result of, among other things, completion of customary quarterly review and audit procedures.

Management to Present at J.P. Morgan Healthcare Conference

Allscripts management will conduct a presentation for investors on January 15, 2020, at 4:00 p.m. PT during the J.P. Morgan Healthcare Conference in San Francisco. A webcast link to this event and a presentation will be available at the Allscripts investor relations website.

Footnotes

(1)

Bookings have been determined on a continuing operations basis, excluding Netsmart, and reflect the value of executed contracts for software, hardware, client services, private cloud hosting services, outsourcing and other subscription-based services.

Non-GAAP revenue consists of GAAP revenue, as reported, and adds back recognized deferred revenue from the EIS business, Practice Fusion, HealthGrid, NantHealth’s provider/patient solutions business and non-material consolidated affiliates that is eliminated for GAAP purposes due to purchase accounting adjustments.

Non-GAAP net income consists of GAAP net income/(loss), as reported, and adds back acquisition-related deferred revenue adjustments; acquisition-related amortization; stock-based compensation expense; transaction, legal and other costs; non-cash asset and long-term investment impairment charges; non-cash charges to interest expense and other, asset impairment charges; gain on sale of business, net; and equity in net earnings of unconsolidated investments and the related tax effect of the aforementioned adjustments. Non-GAAP net income also includes a GAAP to non-GAAP tax rate alignment adjustment.

Non-GAAP net income attributable to Allscripts Healthcare Solutions, Inc. is a non-GAAP measure and consists of non-GAAP net income, as described above, with an adjustment to reduce non-GAAP net income for the percentage of non-controlling interest outside Allscripts ownership position.

Non-GAAP earnings per share consist of non-GAAP net income, as defined above, divided by weighted shares outstanding – diluted during the applicable period.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, including the preliminary financial information included in this release, are based on the current beliefs and expectations of Allscripts management, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual results could differ significantly from those set forth in the forward-looking statements and reported results should not be considered an indication of future performance. Certain factors that could cause Allscripts actual results to differ materially from those described in the forward-looking statements include, but are not limited to: the final outcome of the criminal and civil investigations by the DOJ involving Practice Fusion, including our ability to negotiate final settlement agreements with the DOJ and the terms of such agreements; potential additional investigations and proceedings from governmental entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ’s investigations into Practice Fusion’s business practices; the expected financial results of businesses acquired by us; the successful integration of businesses acquired by us; the anticipated and unanticipated expenses and liabilities related to businesses acquired by us, including the civil investigation by the U.S. Attorney’s Office involving our EIS business; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; Allscripts ability to establish and maintain strategic relationships, including the recent strategic partnerships announced by our Veradigm business unit; Allscripts failure to compete successfully; consolidation in Allscripts industry; current and future laws, regulations and industry initiatives; increased government involvement in Allscripts industry; the failure of markets in which Allscripts operates to develop as quickly as expected; Allscripts or its customers’ failure to see the benefits of government programs; changes in interoperability or other regulatory standards; the effects of the realignment of Allscripts sales, services and support organizations; market acceptance of Allscripts products and services; the unpredictability of the sales and implementation cycles for Allscripts products and services; Allscripts ability to manage future growth; Allscripts ability to introduce new products and services; the performance of Allscripts products; Allscripts ability to protect its intellectual property rights; the outcome of legal proceedings involving Allscripts; Allscripts ability to hire, retain and motivate key personnel; performance by Allscripts content and service providers; liability for use of content; price reductions; Allscripts ability to license and integrate third party technologies; Allscripts ability to maintain or expand its business with existing customers; risks related to international operations; changes in tax rates or laws; business disruptions; Allscripts ability to maintain proper and effective internal controls; and asset and long-term investment impairment charges. Additional information about these and other risks, uncertainties, and factors affecting Allscripts business is contained in Allscripts filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in the most recent Allscripts Annual Report on Form 10-K and subsequent Form 10-Qs. Allscripts does not undertake to update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in its business, financial condition or operating results over time.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions, Inc.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:  

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

01/13/2020

Northwell Health Extends Allscripts® Managed Services Agreement Through 2026

CHICAGO–(BUSINESS WIRE)–Jan. 13, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Northwell Health, New York State’s largest health system, has extended its engagement with Allscripts Managed Services through 2026. The health system has used the Allscripts services offering since 2004 and currently employs it enterprise-wide, which includes 23 hospitals and more than 700 physician practices.

Allscripts Managed Services supports an organization’s infrastructure as well as Allscripts solutions and third-party applications. It also provides comprehensive service desk support and application management services, as well as engages in project delivery, strategic and leadership-planning activities.

The Managed Services extension had a modest impact on 2019 fourth-quarter bookings and is expected to add approximately $500 million to contract backlog as of December 31, 2019. This extension follows a previously announced extension earlier in 2019 for Northwell Health’s continued use of the Allscripts Sunrise™ electronic health record platform in its hospital network, as well as the extension in 2018 for continued use of the Allscripts TouchWorks® EHR platform in its physician practice network. Allscripts and Northwell Health also announced in 2019 plans to jointly develop a next-generation electronic health record platform.

“The strong, long-standing partnership between Northwell Health and Allscripts has helped fuel our organization’s mission of improving the health of our communities,” said Michael Dowling, Northwell Health’s president and chief executive officer. “Over the years Allscripts has been our trusted partner every step of the way, supporting us as we have grown and evolved to best meet the needs of our patients, clinicians and administrative staff. I look forward to Allscripts continuing to be a key component of the engine that drives Northwell Health’s success.”

“Northwell Health, our largest client, is truly driven to advance the health of its community and we are honored to continue pursuing our shared vision with such a visionary leader in the healthcare industry,” said Allscripts CEO Paul Black. “We have shared many successes over the course of our 15-year partnership with Northwell, and this extension—along with the system’s extension of its Sunrise engagement and our joint development of healthcare’s next-generation electronic health record—ensures that many more achievements are yet to come.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

12/12/2019

Pulse8 Presenting on the Shift to Digital HEDIS® Measures during the RISE Star Ratings Master Class in Carlsbad, CA

CHICAGO–(BUSINESS WIRE)–Dec. 12, 2019–
Back for its 10th year, the RISE Star Ratings Master Class offers a deep dive for Medicare Advantage health plans seeking actionable strategies to boost their Star Rating. This conference focuses on key trends and knowledge sharing from leading innovators including Pulse8.

This year’s Master Class includes Pulse8’s Sharalee Johnson, Director of Quality Solutions, presenting to attendees on how to prepare for the shift to digital HEDIS® measures on Thursday, December 12, from 1:30-2:15pm PST at the Omni La Costa Resort in Carlsbad, CA.

During this session, attendees will learn how to:

  • Gain more insights into Digital and Electronic Clinical Data Systems (ECDS) measurement reporting for HEDIS®
  • Make performance data accessible at the point of care
  • Understand steps you can take today to prepare for the shift

“I’m privileged to be a part of this year’s educational agenda at the RISE Star Ratings Master Class to help attendees learn more about the shift to digital HEDIS® measures and ECDS, as this will be a game changer for the industry meant to increase the efficiency of Quality reporting and documenting member centered care,” Johnson said. “This new method of reporting is significant and will greatly help in terms of being able to acquire actionable insight from a wealth of data that will lead to better management of healthcare for individuals and groups.”

Attendees will have an opportunity to visit the Pulse8 booth to speak with Sharalee and other key members of the team. To schedule a meeting or demo, please email Info@Pulse8.com.

About Pulse8

Pulse8, a Veradigm™ brand, is a Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Our advanced analytic methodologies and flexible business intelligence tools offer real-time visibility into member behavior and provider performance. Pulse8’s Illumin8 Active Intelligence™ platform offers a suite of uniquely pragmatic solutions that are powered by our patent-pending Dynamic Intervention Planning to deliver the most cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality. For more company information or to schedule a demo, please Info@Pulse8.com.

About Veradigm™

Veradigm is an integrated data systems and services business that combines data-driven clinical insights with actionable tools for clinical workflow, research, analytics, and media. Our solutions are designed to help key healthcare stakeholders to improve the quality, efficiency, and value of healthcare delivery – from biopharma to health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. That is how we are transforming health, insightfully. To learn more, visit www.veradigmhealth.com. Veradigm™ is a business unit of Allscripts.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About RISE (Resource Initiative and Society for Education)

RISE is the first national association totally dedicated to enabling healthcare professionals working in organizations and aspiring to meet the challenges of the emerging landscape of accountable care and health care reform. We strive to serve our members on four fronts: Education, Industry Intelligence, Networking and Career Development.

© 2019 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

stephen.shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

tom.lynch@allscripts.com

12/10/2019

Wyckoff Heights Medical Center goes live with Sunrise EHR

Sunrise™ Acute Care, Sunrise™ Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM Sunrise™ Pharmacy now deployed, as well Allscripts patient engagement platform, FollowMyHealth®; extends and expands Managed Services engagement

CHICAGO–(BUSINESS WIRE)–Dec. 10, 2019–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that client Wyckoff Heights Medical Center is now live on its Sunrise™ platform, which includes Sunrise™ Acute Care, Sunrise Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM and Sunrise™ Pharmacy as well as Allscripts patient engagement platform, FollowMyHealth®.

Wyckoff Heights Medical Center provides care with kindness. More than 250,000 patient visits for acute, emergency, and surgical services and ambulatory care at locations on the border of Brooklyn and Queens, New York. The organization uses the integrated suite of Allscripts Sunrise solutions which supports the transition to value-based care and to improve clinical decision support. The medical center also recently purchased CarePort™, Allscripts care coordination suite of solutions to help ensure smooth transitions of care across the entire care continuum.

“We selected the Sunrise comprehensive platform to help us drive better care delivery while promoting high levels of patient satisfaction and lowered clinician burnout,” says Ramon Rodriguez, President and CEO of Wyckoff Heights Medical Center. “Our partnership with Allscripts has proved successful and we look forward to seeing results across our entire system. No transition between platforms is without challenges and ours have benefited from the commitment of our Wyckoff staff and the excellent support of the Allscripts crew of onsite advisors. As a customer, I am very satisfied with Allscripts commitment to our needs for customization and on-site learning.”

Used by many of the leading hospitals and health systems in the world, Sunrise is a highly configurable solution that offers clinician-specific workflows that help drive adoption of clinical decision support that leads to improved outcomes. Wyckoff Heights Medical Center is Allscripts first client in New York State to go live on the entire Sunrise™ Financial Manager platform, which will enable the organization to meet the applicable New York state regulatory requirements.

“With the Sunrise suite of solutions, Wyckoff Heights Medical Center has put the organization, its clinicians and, most importantly, its patients in a great position for significantly improved outcomes,” CEO Paul Black says. “Our partnership will continue to yield great results for the Wyckoff Heights community.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

12/05/2019

Allscripts Announces Pricing of $200 Million Convertible Senior Notes Offering

CHICAGO–(BUSINESS WIRE)–Dec. 5, 2019–
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (“Allscripts”) today announced the pricing of its previously disclosed private offering of $200 million aggregate principal amount of its 0.875% convertible senior notes due 2027 (the “notes”). Allscripts has also granted the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering and sale of the notes to the initial purchasers is expected to close on December 9, 2019, subject to customary closing conditions.

The notes are senior, unsecured obligations of Allscripts and bear interest at a rate of 0.875% per year, payable semiannually in arrears on January 1 and July 1 of each year, commencing on July 1, 2020. The notes will be convertible at the option of the holders only in certain circumstances and during certain periods. Conversions of the notes may be settled in cash, shares of Allscripts’ common stock, or a combination of cash and shares of Allscripts’ common stock, at Allscripts’ election. Allscripts will not have the right to redeem the notes prior to maturity. The notes will mature on January 1, 2027, unless earlier repurchased or converted in accordance with their terms prior to such date. The initial conversion rate for the notes will be 75.0962 shares of Allscripts’ common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $13.32 per share of Allscripts’ common stock. The initial conversion price of the notes represents a premium of approximately 32.5% to the $10.05 per share last reported sale price of Allscripts’ common stock on December 4, 2019.

Allscripts estimates that the net proceeds from the offering will be approximately $195.0 million (assuming no exercise of the initial purchasers’ option to purchase additional notes), after deducting the initial purchasers’ discount but before estimated offering expenses. Allscripts intends to use $15.8 million of the net proceeds to pay the cost of capped call transactions described below, and Allscripts expects to use the remaining net proceeds to repay outstanding borrowings under its senior secured revolving credit facility.

In connection with the pricing of the notes, Allscripts entered into privately negotiated capped call transactions with JPMorgan Chase Bank, National Association, Wells Fargo Bank, National Association, Bank of America, N.A. and Deutsche Bank AG, London Branch (the “option counterparties”). The capped call transactions are expected generally to reduce the potential dilution to Allscripts’ common stock upon any conversion of notes and/or offset any cash payments Allscripts is required to make in excess of the principal amount of the converted notes, as the case may be, in the event that the market price of Allscripts’ common stock is greater than the strike price of the capped call transactions (which initially corresponds to the initial conversion price of the notes and is subject to certain adjustments under the terms of the capped call transactions), with such reduction and/or offset subject to a cap based on the cap price of the capped call transactions. The cap price of the capped call transactions is initially $17.5875 per share, representing a premium of 75% above the last reported sale price of $10.05 per share of Allscripts’ common stock on December 4, 2019, and is subject to certain adjustments under the terms of the capped call transactions. If the initial purchasers exercise their option to purchase additional notes, Allscripts intends to enter into one or more additional capped call transactions with the option counterparties.

Allscripts expects that in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to Allscripts’ common stock and/or purchase shares of Allscripts’ common stock concurrently with, or shortly after, the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Allscripts’ common stock or the notes at that time. In addition, Allscripts expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Allscripts’ common stock and/or purchasing or selling shares of Allscripts’ common stock or other securities of Allscripts in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period relating to a conversion of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Allscripts’ common stock or the notes, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, could affect the number of shares and the value of the consideration that noteholders will receive upon conversion of the notes.

Neither the notes nor the shares of Allscripts’ common stock issuable upon conversion of the notes, if any, nor the capped call transactions have been, nor will be, registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements.

This press release is not an offer to sell, or a solicitation of an offer to purchase, any securities of Allscripts. It is issued pursuant to Rule 135c under the Securities Act.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, expectations regarding the notes offering and capped call transactions, the closing of the notes offering, the actions of the option counterparties with respect to the capped call transactions, and Allscripts’ anticipated use of net offering proceeds. These forward-looking statements are based on the current assumptions, expectations and beliefs of Allscripts’ management, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual results could differ significantly from those set forth in the forward-looking statements and reported results should not be considered an indication of future performance. Certain factors that could cause Allscripts’ actual results to differ materially from those described in the forward-looking statements include, but are not limited to: risks related to market and other general economic conditions, Allscripts’ ability to satisfy the closing conditions required for the consummation of the notes offering and the capped call transactions, the final outcome of the criminal and civil investigations by the Department of Justice (the “DOJ”) involving Practice Fusion, Inc. (“Practice Fusion), including our ability to negotiate final settlement agreements with the DOJ and the terms of such agreements; potential additional investigations and proceedings from governmental entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ’s investigations into Practice Fusion’s business practices; the expected financial results of businesses acquired by us, including the McKesson Corporations Enterprise Information Solutions (“EIS”) portfolio (the “EIS Business”), the NantHealth, Inc. (“NantHealth”) provider/patient solutions business, Practice Fusion and Health Grid Holding Company (“Health Grid”); the successful integration of businesses recently acquired by us; the anticipated and unanticipated expenses and liabilities related to the EIS Business, the NantHealth provider/patient solutions business, Practice Fusion and HealthGrid, including the civil investigation by the U.S. Attorney’s Office involving our EIS Business; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; Allscripts’ failure to compete successfully; consolidation in Allscripts’ industry; current and future laws, regulations and industry initiatives; increased government involvement in Allscripts’ industry; the failure of markets in which Allscripts operates to develop as quickly as expected; Allscripts’ or its customers’ failure to see the benefits of government programs; changes in interoperability or other regulatory standards; the effects of the realignment of Allscripts’ sales, services and support organizations; market acceptance of Allscripts’ products and services; the unpredictability of the sales and implementation cycles for Allscripts’ products and services; Allscripts’ ability to manage future growth; Allscripts’ ability to introduce new products and services; Allscripts’ ability to establish and maintain strategic relationships; risks related to the acquisition of new businesses or technologies; the performance of Allscripts’ products; Allscripts’ ability to protect its intellectual property rights; the outcome of legal proceedings involving Allscripts; Allscripts’ ability to hire, retain and motivate key personnel; performance by Allscripts’ content and service providers; liability for use of content; price reductions; Allscripts’ ability to license and integrate third party technologies; Allscripts’ ability to maintain or expand its business with existing customers; risks related to international operations; changes in tax rates or laws; business disruptions; Allscripts’ ability to maintain proper and effective internal controls; and asset and long-term investment impairment charges. Additional information about these and other risks, uncertainties, and factors affecting Allscripts’ business is contained in Allscripts’ filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in the Allscripts Annual Report on Form 10-K for 2018, subsequent Quarterly Reports on Form 10-Q and other public filings with the SEC. Allscripts does not undertake to update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in its business, financial condition or operating results over time.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions, Inc.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

12/03/2019

Allscripts Announces $200 Million Convertible Senior Notes Offering

CHICAGO–(BUSINESS WIRE)–Dec. 3, 2019–
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (“Allscripts”) today announced the commencement of a private offering of $200 million aggregate principal amount of its convertible senior notes due 2027 (the “notes”), subject to market and other conditions. Allscripts also expects to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $30 million aggregate principal amount of the notes. The notes will be offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

The notes will be senior, unsecured obligations of Allscripts, and interest on the notes will be payable semiannually in arrears. The notes will be convertible at the option of the holders only in certain circumstances and during certain periods. Conversions of the notes may be settled in cash, shares of Allscripts’ common stock, or a combination of cash and shares of Allscripts’ common stock, at Allscripts’ election. Allscripts will not have the right to redeem the notes prior to maturity. The notes are expected to mature on January 1, 2027, unless earlier repurchased or converted in accordance with their terms prior to such date. The interest rate, conversion rate and certain other terms of the notes will be determined by negotiations between Allscripts and the initial purchasers.

Allscripts expects to use a portion of the net proceeds from the offering to pay the cost of capped call transactions described below, and Allscripts expects to use the remaining net proceeds to repay outstanding borrowings under its senior secured revolving credit facility.

In connection with the pricing of the notes, Allscripts intends to enter into one or more privately negotiated capped call transactions with certain of the initial purchasers and/or their respective affiliates (the “option counterparties”). The capped call transactions are expected generally to reduce the potential dilution to Allscripts’ common stock upon any conversion of notes and/or offset any cash payments Allscripts is required to make in excess of the principal amount of the converted notes, as the case may be, in the event that the market price of Allscripts’ common stock is greater than the strike price of the capped call transactions (which will initially correspond to the initial conversion price of the notes and is subject to certain adjustments under the terms of the capped call transactions), with such reduction and/or offset subject to a cap based on the cap price of the capped call transactions. If the initial purchasers exercise their option to purchase additional notes, Allscripts intends to enter into one or more additional capped call transactions with the option counterparties.

Allscripts expects that in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to Allscripts’ common stock and/or purchase shares of Allscripts’ common stock concurrently with, or shortly after, the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Allscripts’ common stock or the notes at that time. In addition, Allscripts expects that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Allscripts’ common stock and/or purchasing or selling shares of Allscripts’ common stock or other securities of Allscripts in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period relating to a conversion of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Allscripts’ common stock or the notes, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, could affect the number of shares and the value of the consideration that noteholders will receive upon conversion of the notes.

Pursuant to Allscripts’ publicly announced stock repurchase program, Allscripts opportunistically purchases shares of its common stock and may, in compliance with the provisions of Rule 10b-18 under the Securities Exchange Act of 1934, as amended, purchase shares of Allscripts’ common stock pursuant to open market transactions prior to the pricing of this offering. This activity could increase (or reduce the size of any decrease in) the market price of Allscripts’ common stock at that time and/or the conversion price of the notes.

Neither the notes nor the shares of Allscripts’ common stock issuable upon conversion of the notes, if any, nor the capped call transactions have been, nor will be, registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements.

This press release is not an offer to sell, or a solicitation of an offer to purchase, any securities of Allscripts. It is issued pursuant to Rule 135c under the Securities Act.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, expectations regarding the notes offering and capped call transactions, the anticipated principal amount of securities to be sold, the actions of the option counterparties with respect to the capped call transactions, the final terms of the offering and Allscripts’ anticipated use of net offering proceeds. These forward-looking statements are based on the current assumptions, expectations and beliefs of Allscripts’ management, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual results could differ significantly from those set forth in the forward-looking statements and reported results should not be considered an indication of future performance. Certain factors that could cause Allscripts’ actual results to differ materially from those described in the forward-looking statements include, but are not limited to: risks related to market and other general economic conditions, Allscripts’ ability to satisfy the closing conditions required for the consummation of the notes offering and the capped call transactions, the final outcome of the criminal and civil investigations by the Department of Justice (the “DOJ”) involving Practice Fusion, Inc. (“Practice Fusion), including our ability to negotiate final settlement agreements with the DOJ and the terms of such agreements; potential additional investigations and proceedings from governmental entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ’s investigations into Practice Fusion’s business practices; the expected financial results of businesses acquired by us, including the McKesson Corporations Enterprise Information Solutions (“EIS”) portfolio (the “EIS Business”), the NantHealth, Inc. (“NantHealth”) provider/patient solutions business, Practice Fusion and Health Grid Holding Company (“Health Grid”); the successful integration of businesses recently acquired by us; the anticipated and unanticipated expenses and liabilities related to the EIS Business, the NantHealth provider/patient solutions business, Practice Fusion and HealthGrid, including the civil investigation by the U.S. Attorney’s Office involving our EIS Business; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; Allscripts’ failure to compete successfully; consolidation in Allscripts’ industry; current and future laws, regulations and industry initiatives; increased government involvement in Allscripts’ industry; the failure of markets in which Allscripts operates to develop as quickly as expected; Allscripts’ or its customers’ failure to see the benefits of government programs; changes in interoperability or other regulatory standards; the effects of the realignment of Allscripts’ sales, services and support organizations; market acceptance of Allscripts’ products and services; the unpredictability of the sales and implementation cycles for Allscripts’ products and services; Allscripts’ ability to manage future growth; Allscripts’ ability to introduce new products and services; Allscripts’ ability to establish and maintain strategic relationships; risks related to the acquisition of new businesses or technologies; the performance of Allscripts’ products; Allscripts’ ability to protect its intellectual property rights; the outcome of legal proceedings involving Allscripts; Allscripts’ ability to hire, retain and motivate key personnel; performance by Allscripts’ content and service providers; liability for use of content; price reductions; Allscripts’ ability to license and integrate third party technologies; Allscripts’ ability to maintain or expand its business with existing customers; risks related to international operations; changes in tax rates or laws; business disruptions; Allscripts’ ability to maintain proper and effective internal controls; and asset and long-term investment impairment charges. Additional information about these and other risks, uncertainties, and factors affecting Allscripts’ business is contained in Allscripts’ filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in the Allscripts Annual Report on Form 10-K for 2018, subsequent Quarterly Reports on Form 10-Q and other public filings with the SEC. Allscripts does not undertake to update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in its business, financial condition or operating results over time.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Source: Allscripts Healthcare Solutions, Inc.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

Scroll To Top